Oramed Pharmaceuticals (ORMP) Prepaid Assets (2011 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Prepaid Assets came in at $2.3 million in Q1 2026, up 177.64% YoY from $832000.0 in Q1 2025, and down 15.72% on a QoQ basis from $2.7 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Prepaid Assets (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 16 years of Prepaid Assets data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Prepaid Assets rose 177.64% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 177.64% YoY) and the FY2025 annual result came in at $2.7 million, up 112.32% from the prior year.
- Prepaid Assets retreated to $2.3 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.7 million in Q4 2025 to a low of $474000.0 in Q3 2024.
- A 5-year average of $1.1 million and a median of $958000.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets slumped 64.79% — and 2025, when it jumped 201.69%.
- Tracing ORMP's Prepaid Assets over 5 years: stood at $1.4 million in 2022, then plunged by 61.34% to $537000.0 in 2023, then soared by 140.41% to $1.3 million in 2024, then soared by 112.32% to $2.7 million in 2025, then decreased by 15.72% to $2.3 million in 2026.
- The last three Prepaid Assets figures came in at $2.3 million (Q1 2026), $2.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.17 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 832,000.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 474,000.00 |
| Jun 30, 2024 | 533,000.00 |
| Mar 31, 2024 | 501,000.00 |
| Dec 31, 2023 | 537,000.00 |
| Sep 30, 2023 | 666,000.00 |
| Jun 30, 2023 | 769,000.00 |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Sep 30, 2022 | 623,000.00 |
| Jun 30, 2022 | 958,000.00 |
| Mar 31, 2022 | 1.95 Mn |
| Nov 30, 2021 | 1.80 Mn |
| Aug 31, 2021 | 1.20 Mn |